Alnylam Pharmaceuticals partners with the Rare Diseases Foundation to reward
an innovative project in the field of rare diseases with a grant of 20 000 €.
The project should address one or both of the following themes:
- Translational project developing an RNA interference approach and using a
animal or cell model expressing the targeted pathology.
- Innovative vectoring of interfering RNA targeting an organ or tissue.
Application deadline: March 31, 2022
To download the text of the Award: click here